229Grandis JR, Falkner DM, Melhem MF, Gooding WE, Drenning SD, Morel PA (2000) Human
leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and
neck: clinical and immunogenetic consequences. Clin Cancer Res 6:2794–2802
Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the
tumor microenvironment. Cancer Cell 21:309–322
Harada T, Shinohara M, Nakamura S, Oka M (1994) An immunohistochemical study of the extra-
cellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic
potential. Virchows Arch 424:257–266
He KF, Zhang L, Huang CF, Ma SR, Wang YF, Wang WM et al (2014) CD163+ tumor-associated
macrophages correlated with poor prognosis and cancer stem cells in oral squamous cell carci-
noma. Biomed Res Int 2014:838632
Heddleston J, Li Z, Lathia J, Bao S, Hjelmeland A, Rich J (2010) Hypoxia inducible factors in
cancer stem cells. Br J Cancer 102:789–795
Hida K, Hida Y, Amin DN, Flint AF, Panigrahy D, Morton CC et al (2004) Tumor-associated endo-
thelial cells with cytogenetic abnormalities. Cancer Res 64:8249–8255
Hjelmeland AB, Wu Q, Heddleston J, Choudhary G, MacSwords J, Lathia JD et al (2011) Acidic
stress promotes a glioma stem cell phenotype. Cell Death Differ 18:829–840
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an
evolving paradigm. Nat Rev Cancer 13:714–726
Hovinga KE, Shimizu F, Wang R, Panagiotakos G, Van Der Heijden M, Moayedpardazi H et al
(2010) Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial
cell intermediate. Stem Cells 28:1019–1029
Hu Y, He MY, Zhu LF, Yang CC, Zhou ML, Wang Q et al (2016) Tumor-associated macrophages
correlate with the clinicopathological features and poor outcomes via inducing epithelial to
mesenchymal transition in oral squamous cell carcinoma. J Exp Clin Cancer Res 35:12
Huang Z, Wang L, Wang Y, Zhuo Y, Li H, Chen J et al (2013) Overexpression of CD147 contrib-
utes to the chemoresistance of head and neck squamous cell carcinoma cells. J Oral Pathol
Med 42:541–546
Huang Z, Tan N, Guo W, Wang L, Li H, Zhang T et al (2014) Overexpression of EMMPRIN iso-
form 2 is associated with head and neck cancer metastasis. PLoS One 9:e91596
Huntly BJ, Gilliland DG (2005) Leukaemia stem cells and the evolution of cancer-stem-cell
research. Nat Rev Cancer 5:311–321
Ishikawa T, Nakashiro K, Klosek SK, Goda H, Hara S, Uchida D et al (2009) Hypoxia enhances
CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma. Oncol Rep
21:707–712
Jiang J, Tang YL, Liang XH (2011) EMT: a new vision of hypoxia promoting cancer progression.
Cancer Biol Ther 11:714–723
Johansson N, Airola K, Grenman R, Kariniemi A-L, Saarialho-Kere U, Kähäri V (1997) Expression
of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and
neck. Am J Pathol 151:499
Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10–producing,
nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with alloge-
neic immature human dendritic cells. J Exp Med 192:1213–1222
Judd NP, Winkler AE, Murillo-Sauca O, Brotman JJ, Law JH, Lewis JS et al (2012) ERK1/2 regu-
lation of CD44 modulates oral cancer aggressiveness. Cancer Res 72:365–374
Kamarajan P, Shin JM, Qian X, Matte B, Zhu JY, Kapila YL (2013) ADAM17-mediated CD44
cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC. Cancer
Med 2:793–802
Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer develop-
ment and progression. Nat Rev Immunol 5:749–759
Kawashiri S, Tanaka A, Noguchi N, Hase T, Nakaya H, Ohara T et al (2009) Significance of
stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell car-
cinoma of the oral cavity. Head Neck 31:1346–1353
11 Oral Cancer Stem Cells Microenvironment